Interv Akut Kardiol. 2010;9(1):20-26
Hypertrophic cardiomyopathy is an autosomal dominant disease with prevalence of 0,2 % and with asymetric hypertrophy of left ventricle
(> 15 mm). Obstructive form is clinically more significant and has worse prognosis. As a cause of this disease more than 200 mutations on
more than 10 genes were diagnosed till now. Symptomatology and prognosis of hypertophic cardiomyopathy is heterogenous – from
asymptomatic course to sudden death. Angina pectoris, effort dyspnoe or syncope are the most common symptoms. Mortality is estimated
1 % to 6 %. Obstructive form is characterized by resting or provoked gradient > 30 mm Hg. In patients with obstructive form the risk
of death, stroke and heart failure is higher as well as the risk of disease progression into the NYHA class III or IV. In the treatment of this
disease drugs, A-V sequential stimulation, surgical myectomy or alcohol septal ablation (ASA) are used. The most effective treatment of
obstructive form are surgical myectomy and ASA. Both methods are connected with low mortality, both procedures significantly improve
symptomatology of the patients, surgical myectomy improves patient´s prognosis. Lowering of resting and provoked gradients, favourable
remodeling of the left ventricle and the left atrium, decreasing of the severity of SAM and increasing of effort tolerance are seen during
follow-up. A-V block with permanent pacemaker implantation and right bundle branch block are more common after ASA, left bundle
branch block is more common after surgical myectomy. Aortic valve insufficiency, atrial fibrilation and stroke are sparse complications of
surgical myectomy. ASA is performed more often in older polymorbid patients, surgical myectomy in younger patients with associated
aortic or mitral valve disease. The principles and comparison of both methods from many perspectives are given in this review.
Published: March 1, 2010 Show citation